FdaApplication
ANDA 203332
Identifiers
- fda_app_no: ANDA203332
Properties
| Property | Value |
|---|---|
| applicant_name | ADAPTIS |
| application_type | ANDA |
| approval_date | 2020-03-12 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
4 products